Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Capecitabine and Pyrotinib|DRUG: Capecitabine,Trastuzumab, and Pertuzumab
Sponsor: Shandong Cancer Hospital and Institute